Efficacy and Safety of Traditional Chinese Medicine in Idiopathic Pulmonary Fibrosis: A Meta-Analysis

医学 内科学 DLCO公司 荟萃分析 子群分析 科克伦图书馆 安慰剂 不利影响 特发性肺纤维化 肺功能测试 随机对照试验 中医药 肺功能 肺 扩散能力 病理 替代医学
作者
Kun Ji,MA Jian-ling,WANG Liangmin,Niuniu Li,Shangjuan Dong,Shi Li-qing
出处
期刊:Evidence-based Complementary and Alternative Medicine [Hindawi Publishing Corporation]
卷期号:2020: 1-11 被引量:15
标识
DOI:10.1155/2020/1752387
摘要

To evaluate the efficacy and safety of traditional Chinese medicine (TCM) on lung function and quality of life of idiopathic pulmonary fibrosis (IPF) patients by meta-analysis.Randomized controlled trials (RCTs) related to TCM and IPF were searched on PubMed, EMBASE Cochrane Library, ClinicalTrials, China National Knowledge Infrastructure (CNKI), Wanfang Database, Chin VIP Information (VIP), and Chinese Biomedical Database (CBM) until December 2018. Standard mean difference (SMD) and 95% CI were calculated for the measurements related to lung function (FEV1/FVC, FVC%, FEV1%, TLC%, DLCO% or DLCO, and VC%) and other parameters (PO2, 6MWD, and SGRQ) when comparing TCM treatment to the control group. Relative risk (RR) and 95% CI of adverse events (AEs) were calculated to assess the safety of TCM.A total of 40 RCTs comparing TCM to western medicine (WM) and involving 3194 IPF patients were eligible for the meta-analysis. The pooled results showed that TCM treatment improved significantly PO2 (SMD = 0.80, 95% CI 0.54 to 1.06, p < 0.001), FEV1% (SMD = 0.57, 95% CI 0.42 to 0.71, p < 0.001), DLCO% (SMD = 0.38, 95% CI 0.28 to 0.48, p < 0.001), 6MWD (SMD = 0.70, 95% CI 0.56 to 0.84, p < 0.001) and other measurements and reduced SGRQ scores (SMD = −0.51, 95% CI −0.70 to −0.22, p < 0.001). Subgroup analysis of different study durations (3 months, ≥ 6 months) and comparison models (TCM vs. WM, TCM + WM vs. WM or TCM vs. placebo) showed similar results. No significant difference of risk of AEs was observed between both groups (RR = 0.66, 95% CI: 0.27–1.60, p=0.352). There was no obvious publication bias, and the pooled results were stable according to sensitivity analysis.To the best of our knowledge, the present study had the largest sample size. Our results indicated that TCM treatment may help provide benefit to the lung function, exercise capacity, and quality of life of IPF patients, alone or combined with WM, when compared to WM. More rigorous RCTs were needed in the future.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Micalblame发布了新的文献求助200
刚刚
有谁共鸣完成签到,获得积分10
刚刚
刚刚
刚刚
Sin完成签到,获得积分10
刚刚
1秒前
东风发布了新的文献求助10
1秒前
1秒前
CodeCraft的应助被跋扈采纳,获得10
1秒前
1秒前
1秒前
zl完成签到 ,获得积分10
2秒前
2秒前
chenxi3099完成签到,获得积分10
2秒前
2秒前
FashionBoy的应助被Doc邓爱科研采纳,获得10
2秒前
曜布稻泰完成签到,获得积分10
2秒前
upupup完成签到,获得积分10
2秒前
3秒前
Ava的应助被ezreal采纳,获得10
3秒前
风趣的洙发布了新的文献求助10
3秒前
吱5吱发布了新的文献求助10
4秒前
XiaoTong发布了新的文献求助10
4秒前
comrade_zoe完成签到,获得积分10
5秒前
gao发布了新的文献求助10
5秒前
英勇溪流发布了新的文献求助20
5秒前
田様的应助被吃饭了吗123采纳,获得10
5秒前
寂寞的小鱼的应助被DrW采纳,获得10
5秒前
香蕉觅云的应助被hyunjj_niel采纳,获得10
5秒前
5秒前
6秒前
6秒前
6秒前
xyy完成签到 ,获得积分10
6秒前
小胖鱼发布了新的文献求助30
6秒前
6秒前
哇哇发布了新的文献求助10
7秒前
全或无完成签到,获得积分10
7秒前
哈哈哈哈发布了新的文献求助10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Aspects of Post-SPE Phonology 2000
CLSI VET01S Ed7 Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals 1000
Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals 888
Rosenblum, Global Change Biology 800
Holistic Discourse Analysis, Second Edition by Robert E. Longacre (2012-09-10) 666
Berberine regulates the TLR4 signaling pathway to suppress hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells 530
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 物理 有机化学 化学工程 内科学 生物化学 复合材料 催化作用 心理学 细胞生物学 无机化学 电极 光电子学 人工智能
热门帖子
关注 科研通微信公众号,转发送积分 7869277
求助须知:如何正确求助?哪些是违规求助? 9386282
关于积分的说明 20758449
捐赠科研通 7470284
什么是DOI,文献DOI怎么找? 3350215
关于科研通互助平台的介绍 2491267
邀请新用户注册赠送积分活动 2376569